Skip to main content
logo
Bayer Aktiengesellschaft (LON:0P6S)
London flag London · Delayed Price · Currency is GBP · Price in EUR
43.77
-2.18 (-4.74%)
At close: Feb 20, 2026

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Crop Science Revenue
21.61B22.26B23.27B
Crop Science Revenue Growth
-2.91%-4.35%-7.54%
Pharmaceuticals Revenue
18.01B18.13B18.08B
Pharmaceuticals Revenue Growth
-0.66%0.28%-6.08%
Consumer Health Revenue
5.91B5.87B6.03B
Consumer Health Revenue Growth
0.65%-2.60%-0.87%
All Other Segment Revenue
-327.00M238.00M
All Other Segment Revenue Growth
-37.40%9.68%
Enabling Functions and Consolidation Revenue
-19.00M21.00M
Enabling Functions and Consolidation Revenue Growth
--9.52%-

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Europe/Middle East/Africa Revenue
13.60B13.98B14.09B
Europe/Middle East/Africa Revenue Growth
-2.71%-0.75%-2.38%
North America Revenue
16.67B16.48B16.25B
North America Revenue Growth
1.14%1.37%-7.50%
Asia/Pacific Revenue
7.89B8.07B8.37B
Asia/Pacific Revenue Growth
-2.23%-3.56%-11.45%
Latin America Revenue
7.71B8.08B8.93B
Latin America Revenue Growth
-4.57%-9.52%-3.88%

Adjusted EBITDA

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Crop Science Adjusted EBITDA
4.34B4.33B5.04B
Crop Science Adjusted EBITDA Growth
0.32%-14.15%-26.63%
Pharmaceuticals Adjusted EBITDA
4.59B4.72B5.19B
Pharmaceuticals Adjusted EBITDA Growth
-2.90%-9.00%-11.65%
Consumer Health Adjusted EBITDA
1.40B1.37B1.41B
Consumer Health Adjusted EBITDA Growth
2.27%-3.19%3.22%
All Other Segment Adjusted EBITDA
-62.00M163.00M
All Other Segment Adjusted EBITDA Growth
--61.96%7.95%
Enabling Functions and Consolidation Adjusted EBITDA
--352.00M-95.00M
Updated Sep 30, 2025. Data Source: Fiscal.ai.